Pfizer
The swift delivery of the world’s first COVID-19 vaccine put a big spotlight on the promise of mRNA technology, but we think the scientific community is only beginning to tap its potential. The next wave of scientific innovation is upon us, and Pfizer is working hard to harness the power of mRNA. Our expertise in disease biology, along with our robust, rapid manufacturing capabilities, and talented scientific minds will help propel the potential of this technology forward.